Vaxart
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Vaxart and buy or sell other stocks, ETFs, and their options commission-free!About VXRT
Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology oral vaccine platform. Its investigational vaccines are administered using a room temperature-stable tablet, rather than by injection.
CEOSteven Lo
CEOSteven Lo
Employees115
Employees115
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2004
Founded2004
Employees115
Employees115
VXRT Key Statistics
Market cap93.17M
Market cap93.17M
Price-Earnings ratio-1.64
Price-Earnings ratio-1.64
Dividend yield—
Dividend yield—
Average volume770.32K
Average volume770.32K
High today$0.42
High today$0.42
Low today$0.375
Low today$0.375
Open price$0.375
Open price$0.375
Volume764.74K
Volume764.74K
52 Week high$0.98
52 Week high$0.98
52 Week low$0.2606
52 Week low$0.2606
Stock Snapshot
With a market cap of 93.17M, Vaxart(VXRT) trades at $0.41. The stock has a price-to-earnings ratio of -1.64.
On 2025-11-09, Vaxart(VXRT) stock traded between a low of $0.38 and a high of $0.42. Shares are currently priced at $0.41, which is +8.5% above the low and -3.1% below the high.
Vaxart(VXRT) shares are trading with a volume of 764.74K, against a daily average of 770.32K.
In the last year, Vaxart(VXRT) shares hit a 52-week high of $0.98 and a 52-week low of $0.26.
In the last year, Vaxart(VXRT) shares hit a 52-week high of $0.98 and a 52-week low of $0.26.
VXRT News
TipRanks 4d
Vaxart Partners with Dynavax for Oral COVID-19 VaccineElevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
People also own
Based on the portfolios of people who own VXRT. This list is generated using Robinhood data, and it’s not a recommendation.